HomeGeneticsConditionRing chromosome 20 syndrome
Back to Condition
Ring chromosome 20 syndrome
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Ring chromosome 20 syndrome

Ring chromosome 20 syndrome is a rare neurological condition primarily characterized by recurrent, drug-resistant epilepsy in childhood and intellectual disabilities, caused by an abnormal ring-shaped chromosome 20.

Overview

Ring chromosome 20 syndrome is a condition that affects the normal development and function of the brain. The most common feature of this condition is recurrent seizures (epilepsy) in childhood. The seizures may occur during the day or at night during sleep. They are described as focal seizures because they affect only one area of the brain, a region called the frontal lobe. In many cases, the seizures are complex and resistant to treatment with anti-epileptic drugs. Prolonged seizure episodes known as non-convulsive status epilepticus also appear to be characteristic of ring chromosome 20 syndrome. These episodes involve confusion and behavioral changes.

Most people with ring chromosome 20 syndrome also have intellectual disabilities and behavioral difficulties. Although these problems can appear either before or after the onset of epilepsy, they tend to worsen after seizures develop. Major birth defects and differences in facial features can occur in people with ring chromosome 20 syndrome, though these are rare.

Frequency

Ring chromosome 20 syndrome appears to be a rare condition, although its prevalence is unknown. More than 200 affected individuals have been reported in the medical literature.

Causes

Ring chromosome 20 syndrome is caused by a chromosomal abnormality known as a ring chromosome 20 or r(20). A ring chromosome is a circular structure that occurs when a chromosome breaks in two places and its broken ends fuse together. People with ring chromosome 20 syndrome have one copy of this abnormal chromosome in some or all of their cells.

It is not well understood how the ring chromosome causes the signs and symptoms of this syndrome. In some affected individuals, genes near the ends of chromosome 20 are deleted when the ring chromosome forms. Researchers suspect that the loss of these genes may be responsible for epilepsy and other health problems. However, most affected individuals do not have these gene deletions. In these people, the ring chromosome may change the activity of certain genes on chromosome 20, or the chromosome may be unable to copy (replicate) itself normally during cell division. Researchers are still working to determine the precise relationship between the ring chromosome 20 and the characteristic features of the syndrome.

Learn more about the chromosome associated with Ring chromosome 20 syndrome

  • chromosome 20

Inheritance

Ring chromosome 20 syndrome is almost never inherited. A ring chromosome 20 typically occurs as a random event during the formation of reproductive cells (eggs or sperm) or in early embryonic development. Often, the ring chromosome is present in only some of a person's cells. This situation is known as mosaicism.

Most affected individuals have no history of the disorder in their families. However, there have been a few reports of a ring chromosome 20 being passed from a parent to a child.

Other Names

  • R(20) syndrome
  • Ring 20 syndrome
  • Ring chromosome 20
  • Ring chromosome 20 epilepsy syndrome

Frequently Asked Questions

Ring chromosome 20 syndrome typically presents with focal seizures that start in childhood, often during sleep, and are unusually resistant to multiple anti‑seizure medications. The seizures may evolve into non‑convulsive status epilepticus with prolonged confusion or behavioral change. A definitive clue is the presence of a ring chromosome 20 on a high‑resolution karyotype or chromosomal microarray; therefore, genetic testing is essential when the seizure pattern is atypical and drug‑resistant.
Watch for sudden, unexplained confusion, staring spells, slowed speech, or abrupt changes in behavior that last longer than 30 minutes and do not improve with usual seizure rescue medication. If the child is difficult to arouse, has new onset weakness, or shows autonomic changes (e.g., irregular breathing, sweating), call emergency services immediately; prompt EEG evaluation and intravenous anti‑seizure medication can prevent prolonged neuronal injury.
Because conventional anti‑seizure drugs often fail, clinicians may try a combination of newer agents (e.g., levetiracetam, lacosamide, or perampanel) and consider ketogenic diet therapy, which has shown benefit in some refractory focal epilepsies. In selected cases, vagus‑nerve stimulation or responsive neurostimulation may reduce seizure frequency, but surgical resection is rarely an option due to the diffuse nature of the epileptogenic zone. Close follow‑up with an epileptologist is crucial to adjust therapy promptly.
Early intervention is key: enroll in a specialized educational program that offers individualized education plans (IEPs) with a focus on visual supports, small‑group instruction, and speech‑language therapy. Behavioral therapy (e.g., applied behavior analysis) can address impulsivity and social difficulties. Consistent routines, clear expectations, and regular breaks help manage fatigue from seizures. Collaboration between neurologists, developmental pediatricians, and school psychologists ensures accommodations evolve as the child grows.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA